Featured Research

from universities, journals, and other organizations

Closer to finding treament for Duchenne muscular dystrophy

Date:
December 1, 2011
Source:
University of Royal Holloway London
Summary:
Academics have made an important breakthrough in the development of a treatment for Duchenne muscular dystrophy (DMD).

Dystrophin protein in a human muscle cell.
Credit: Image courtesy of University of Royal Holloway London

Academics from Royal Holloway, University of London and a team lead by scientists at the UCL Institute of Child Health (ICH), have made an important breakthrough in the development of a treatment for Duchenne muscular dystrophy (DMD) which in the future could help the likes of the Lloyd family who were featured on a recent X-Factor T.V. show in the U.K.

Related Articles


The family's story was shown before the X Factor stars performed the show's charity song in aid of sick children. In a moving interview the boys' parents Helen and Chris Lloyd spoke about when their identical twins Dan and Sam, 16, were first diagnosed with the genetic disease DMD when they started showing signs of struggling to move.

But the family's ordeal got worse when younger brother Tom, 13, was also diagnosed with the life-limiting condition that affects one in 3,000 male births in the general population, with around 100 cases diagnosed in the UK each year.

Together with the MDEX Consortium, Professor George Dickson from the School of Biological Sciences at Royal Holloway showed that a gene-based drug treatment was effective in restoring the dystrophin protein that is missing in sufferers of DMD, in seven out of 19 trial participants.

DMD causes progressive muscle weakness due to the breakdown and loss of muscle cells. Patients lack a single important protein in their muscle fibres called dystrophin. By the ages of eight to 12, boys become unable to walk and by their late teens or early twenties the condition can become severe enough to limit life expectancy.

In this clinical trial of 19 patients, study participants aged five to 15 at Great Ormond Street Hospital and the Royal Victoria Infirmary, Newcastle, were given weekly doses of the drug, AVI-4658. The drug had already been tested for safety and efficacy by the MDEX Consortium and AVI Biopharma in an earlier phase of the study (Kinali et al, Lancet Neurol 2009).

Professor Dickson said: "Duchenne dystrophy is a very serious inherited disorder which affects 1 in 3,000 boys from age four onwards so to have all three brothers affected by the disease is very rare indeed. It is a progressive and severe muscle wasting disease which is currently untreatable. But our ongoing clinical trials have great promise as a long-term treatment and we hope in future to be able to help transform the lives of families like the Lloyds who have to go through this terrible ordeal."


Story Source:

The above story is based on materials provided by University of Royal Holloway London. Note: Materials may be edited for content and length.


Cite This Page:

University of Royal Holloway London. "Closer to finding treament for Duchenne muscular dystrophy." ScienceDaily. ScienceDaily, 1 December 2011. <www.sciencedaily.com/releases/2011/11/111128121356.htm>.
University of Royal Holloway London. (2011, December 1). Closer to finding treament for Duchenne muscular dystrophy. ScienceDaily. Retrieved October 30, 2014 from www.sciencedaily.com/releases/2011/11/111128121356.htm
University of Royal Holloway London. "Closer to finding treament for Duchenne muscular dystrophy." ScienceDaily. www.sciencedaily.com/releases/2011/11/111128121356.htm (accessed October 30, 2014).

Share This



More Health & Medicine News

Thursday, October 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Mind-Controlled Prosthetic Arm Restores Amputee Dexterity

Reuters - Innovations Video Online (Oct. 29, 2014) A Swedish amputee who became the first person to ever receive a brain controlled prosthetic arm is able to manipulate and handle delicate objects with an unprecedented level of dexterity. The device is connected directly to his bone, nerves and muscles, giving him the ability to control it with his thoughts. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Google To Use Nanoparticles, Wearables To Detect Disease

Google To Use Nanoparticles, Wearables To Detect Disease

Newsy (Oct. 29, 2014) Google X wants to improve modern medicine with nanoparticles and a wearable device. It's all an attempt to tackle disease detection and prevention. Video provided by Newsy
Powered by NewsLook.com
Can Drinking Milk Lead To Early Death?

Can Drinking Milk Lead To Early Death?

Newsy (Oct. 29, 2014) Researchers in Sweden released a study showing heavy milk drinkers face an increased mortality risk from a variety of causes. Video provided by Newsy
Powered by NewsLook.com
Obama: The US Will Not 'run and Hide' From Ebola

Obama: The US Will Not 'run and Hide' From Ebola

AP (Oct. 29, 2014) Surrounded by health care workers in the White House East Room, President Barack Obama said the U.S. will likely see additional Ebola cases in the weeks ahead. But he said the nation can't seal itself off in the fight against the disease. (Oct. 29) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



    Save/Print:
    Share:

    Free Subscriptions


    Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

    Get Social & Mobile


    Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

    Have Feedback?


    Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
    Mobile: iPhone Android Web
    Follow: Facebook Twitter Google+
    Subscribe: RSS Feeds Email Newsletters
    Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins